Pharmaceutical composition for the parenteral administration of ultrashort-effective β-adrenoreceptor antagonists
US11517624B2 · kind B2 · utility
0Cited by
1References
12Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Apr 28, 2020 |
| Grant date | Dec 6, 2022 |
| Priority date | — |
| Expiry date | Apr 28, 2040 |
Classification
- Technology area (CPC B)Performing Operations; Transporting
- CPC primaryB82Y5/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a pharmaceutical composition in the form of a storage-stable solution for the parenteral administration of ultrashort-effective β-adrenoreceptor antagonists, comprising a) an ultrashort-effective β-adrenoreceptor antagonist and/or a pharmaceutically acceptable salt thereof, b) water, and c) a cyclodextrin and/or a functional cyclodextrin derivative. The composition according to the invention has high stability, even without the presence of additional adjuvants.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.